PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 11526676

[STDs today: risk groups and prevention tools].

B Suligoi·M Giuliani
View original source ↗Export metadata ↓

Abstract

The importance of specific programs for controlling and preventing sexually transmitted diseases (STD) has been widely recognized, considering that there exists no treatment that results in complection resolution of sexually transmitted viral pathologies, that many STDs have long periods of infectivity and clinical latency, and that there is a high risk of sequelae and of related oncogenesis. However, STD prevention can be quite complex, in that a variety of diseases with diverse clinical and epidemiological characteristics are currently defined as "STDs". One of the main aspects of STD prevention is the identification of population groups considered to be at risk of transmission and that play an important role in maintaining the current epidemic status of STDs in the general population (i.e., sexually promiscuous persons). As with other diseases, the prevention of STDs is generally classified into primary prevention and secondary prevention. Primary prevention consists of protecting healthy individuals from acquiring the infection and mainly consists of promoting safe-sex (including barrier methods), performing vaccination, and conducting information and education campaigns. The objective of secondary prevention is to prevent the disease from further evolving in persons who are already infected or ill, including the prevention of complications, by providing proper medical care and treatment. The main tools of secondary prevention of STDs are: early diagnosis of cases, early and targeted therapy, and management of sexual partners.

Explore related subjects

HumansRisk FactorsSexually Transmitted DiseasesEnglish AbstractJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

B Suligoi, M Giuliani. 2000. [STDs today: risk groups and prevention tools].. https://pubmed.ncbi.nlm.nih.gov/11526676/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2027

Global Genomic Surveillance.

Global genomic surveillance has emerged as a foundational pillar of public health in the twenty-first century, enabling real-time tracking of pathogen evolution and informing outbreak response. This chapter examines the strategic architecture of global genomic surveillance, focusing on its application to arboviruses such as chikungunya virus (CHIKV). It explores the integration of genomic data with epidemiological, clinical, and environmental information within a One Health framework, while addressing critical challenges in governance, equity, and interoperability. The discussion covers the entire genomic surveillance workflow, from sample collection and sequencing to bioinformatic analysis and phylogenetic inference, and highlights the transformative role of artificial intelligence (AI) in predictive surveillance. By analyzing global initiatives, operational barriers, and emerging technologies, this chapter underscores the necessity of sustainable, equitable, and interoperable genomic systems to proactively address current and future infectious disease threats.

Humans↗
PubMed2027

Systematic Dissection of Key Driver Perturbation Signatures in Single Cells via ECCITE-seq.

CRISPR screens, such as expanded CRISPR-compatible cellular indexing of transcriptomes and epitopes by sequencing (ECCITE-seq), enable the simultaneous measurement of transcriptomes, gRNA identity, and cell-surface protein expression at single-cell resolution to systematically interrogate gene function. This platform provides a powerful and scalable experimental approach for validating disease-associated regulators identified by large-scale association studies and other computational methods, including network-based analyses of multi-omics data. Here, as an example application, we describe an ECCITE-seq framework to characterize the transcriptomic consequences of perturbing multiple neuronal key driver genes associated with Alzheimer's disease (AD) in human-induced pluripotent stem cell (hiPSC)-derived neurons. More broadly, by integrating customized pooled gRNA libraries with different CRISPR effectors across multiple cell types, this approach allows for the assessment of the regulatory impact of candidate genes implicated in development and disease processes.

Humans↗
PubMed2027

Identification of Genome-Wide Chromatin Structural Aberration in Cancer by Hi-C Analysis.

Aberrant three-dimensional genome organization is a hallmark of cancer, often driving oncogene activation through mechanisms such as enhancer hijacking. High-throughput chromosome conformation capture (Hi-C) maps these interactions on a genome-wide scale. Unlike earlier dilution-based methods, in situ Hi-C performs proximity ligation within intact nuclei, minimizing random ligation noise and enabling fine-scale structure detection. This chapter describes an optimized in situ Hi-C protocol tailored for cancer cell lines using MboI digestion and biotin-mediated pull-down to generate high-complexity libraries. We further outline a computational workflow that extends beyond standard topological mapping of compartments and topologically associating domains to identify cancer-specific aberrations. Specifically, we focus on detecting chromosomal rearrangements (structural variants) and characterizing the distinct circular topology of extrachromosomal DNA. This integrated experimental and analytical framework provides the necessary tools to dissect the spatial dysregulation underlying tumor evolution.

Humans↗